Not finding it? Sign in to also search OpenAlex live.
-
Nationwide strategies and outcomes of minimally invasive versus open combined liver ablation and resection for colorectal liver metastases2026 European Journal of Surgical Oncology article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Gabriela Pilz da Cunha, Ketharan Balasupramaniam, Niels Kok, Cornelis Kees Verhoef, Paul D. Gobardhan, Eric R. Manusama, +32 more
0citations -
Laparoscopic versus open parenchymal preserving liver resections in the posterosuperior segments (ORANGE Segments): a multicentre, single-blind, randomised controlled trial2025 The Lancet Regional Health - Europe article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Jasper P. Sijberden, Christoph Kuemmerli, Francesca Ratti, Mathieu D’Hondt, Robert Peter Sutcliffe, Roberto Ivan TROISI, +22 more
15citations -
Laparoscopic versus open resections in the posterosuperior liver segments within an enhanced recovery programme (ORANGE Segments): study protocol for a multicentre randomised controlled trial
Christoph Kuemmerli, Robert S. Fichtinger, Alma L. Moekotte, Luca Antonio Aldrighetti, Somaiah Aroori, Marc G. Besselink, +19 more
20citations -
Robotic Versus Laparoscopic Liver Resection: A Nationwide Propensity Score Matched Analysis2024 Annals of Surgery Open article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Gabriela Pilz da Cunha, Jasper P. Sijberden, Susan van Dieren, Paul D. Gobardhan, Daan J. Lips, Türkan Terkivatan, +25 more
18citations -
Perioperative chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone in gallbladder carcinoma or in front of radical resection in BTC: The phase III GAIN trial.2021 Journal of Clinical Oncology conference-abstract Medicine Cholangiocarcinoma and Gallbladder Cancer Studies
Thorsten Oliver Goetze, Sylvie Lorenzen, Ulli Simone Bankstahl, Sven Arke Lang, Uwe A. Wittel, Steffen Heeg, +14 more
3citations -
Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC): A phase III study utilizing the German Registry of Incidental Gallbladder Carcinoma Platform (GR)—The AIO/CALGP/ACO-GAIN-Trial.2020 Journal of Clinical Oncology conference-abstract Medicine Cholangiocarcinoma and Gallbladder Cancer Studies
Thorsten Oliver Goetze, Ulli Simone Bankstahl, Sven Arke Lang, Steffen Heeg, Wolf O. Bechstein, Andreas Anton Schnitzbauer, +9 more
0citations -
162TiP DEL-LIVER: An open-label, randomized phase II study of melphalan/HDS induction followed by standard therapy vs standard therapy alone in patients with liver-dominant refractory metastatic colorectal cancer
D. Arnold, C. Arslan, T. Wirth, J. Maurel, Michael Moche, K-K. Shiu, +12 more
0citations -
Open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with oxaliplatin and 5-fluorouracil/folinic acid followed by curative surgical resection in patients with hepatic oligometastatic adenocarcinoma of the pancreas (HOLIPANC).2023 Journal of Clinical Oncology conference-abstract Medicine Pancreatic and Hepatic Oncology Research cited by 1 patent
Florian Gebauer, Thomas Schmidt, Alexander Ioannis Damanakis, Alexander Quaas, Duygu Cay, Linde Kehmann, +13 more
0citations -
First safety analysis of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with oxaliplatin and 5-fluoruracil/folinic acid followed by curative surgical resection in patients with hepatic oligometastatic adenocarcinoma of the pancreas (HOLIPANC).2025 Journal of Clinical Oncology conference-abstract Medicine Pancreatic and Hepatic Oncology Research Open access
Dirk Waldschmidt, Nam Gyu Im, Alexander Ioannis Damanakis, Thomas Schmidt, Albrecht Meyer zu Schwabedissen, Alexander Quaas, +13 more
0citations -
Perioperative rifaximin is not associated with enhanced functional and volumetric recovery after major liver resection2021 Scientific Reports article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Jan Bednarsch, Zoltán Czigány, Sven Heiko Loosen, Lara Rosaline Heij, Lorenz Ruckgaber, Henning Maes, +10 more
3citations -
Laparoscopic Versus Open Hemihepatectomy: The ORANGE II PLUS Multicenter Randomized Controlled Trial2024 Journal of Clinical Oncology article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Robert S. Fichtinger, Luca Antonio Aldrighetti, Mohammad Abu Hilal, Roberto Ivan TROISI, Robert Peter Sutcliffe, Marc G. Besselink, +47 more
86citations